Pazeqol 400 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Pazopanib (400mg)
Overview Pazeqol 400 Tablet
Oncaspar 400mg tablets, a protein kinase inhibitor, are indicated for kidney cancer and soft tissue sarcoma. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under your physician's guidance. Common side effects include elevated blood pressure and diarrhea. Regular blood pressure monitoring is often recommended. Manage diarrhea through increased fluid intake or consult your doctor if it's problematic. This medication may decrease blood cell counts, raising infection risk. Report fever, flu-like symptoms, or shortness of breath immediately. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all other medications, particularly those for infections. Numerous drug interactions are possible; inform your healthcare provider of all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout the treatment period.
Uses of Pazeqol 400 Tablet
Renal cell carcinoma and soft tissue sarcoma.
Major Benefits of Pazeqol 400 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Pazeqol 400 Tablet on an empty stomach.
Common Side effects of Pazeqol 400 Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazeqol 400 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the Pazeqol 400 Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Pazeqol 400 Tablet works:
Pazeqol 400mg tablets are an anti-neoplastic agent. Their mechanism of action involves targeted inhibition of tyrosine kinase enzyme receptors, thereby suppressing cancerous cell multiplication. The drug also counteracts tumor angiogenesis, limiting the formation of new blood vessels that nourish the malignancy. This dual action underlies its anticancer efficacy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazeqol 400 Tablet may pose unknown risks. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Pazeqol 400 Tablets during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and the use of Pazeqol 400 Tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking a Pazeqol 400 Tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Pazeqol 400mg tablets are considered safe without requiring any modification to the prescribed dosage.
LiverCAUTION
Patients with liver impairment should use Pazeqol 400 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Pazeqol 400 Tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pazeqol 400 Tablet :
NA
Facts to Know About Pazeqol 400 Tablet
| Label | Value |
|---|---|
| Chemical Category | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently